7:15am ET
Investing
9 Well-Established Companies That Just Refuse to Pay Dividends
24/7 Wall St. has identified nine solid companies that are on very stable ground but that just refuse to pay dividends to their shareholders.
ESRX Coverage Page 4
10:10am ET
Investing
UBS Makes Big Changes to Equity Focus List For March
A new report from UBS shows some serious changes made to the firm's Equity Focus list for March.
4:45pm ET
Health and Healthcare
Is Express Scripts 2015 Guidance Good Enough For All-Time Highs?
ThinkstockAfter the markets closed Monday, Express Scripts Holding Company (NASDAQ: ESRX) reported its fourth-quarter financial results as $1.39 in earnings per share (EPS) and $26.31 billion in revenue. This is compared to…
5:32pm ET
Investing
Meet the 2015 Warren Buffett and Berkshire Hathaway Stocks
courtesy of WhiteHouse.govBerkshire Hathaway Inc. (NYSE: BRK-A) has made its quarterly filing with the Securities & Exchange Commission for its holdings as of December 31, 2014. For all practical purposes, this filing is…
11:25am ET
Retail
Rite Aid PBM Purchase Differentiates It From CVS and Walgreens
Rite Aid has announced that it will acquire EnvisionRx for $2 billion from the private equity firm TPG Capital.
12:20pm ET
Health and Healthcare
What to Expect From Gilead Earnings
Tuesday after the U.S. markets close, Gilead Sciences will report its fourth-quarter financial results.
8:15am ET
Investing
Top Analyst Upgrades and Downgrades: AOL, Caterpillar, Goodyear, Southwest, Synchrony, Yahoo and More
Wednesday's top analyst upgrades, downgrades and initiations include AOL, Caterpillar, Goodyear, Southwest Airlines, Synchrony and Yahoo.
11:00am ET
Health and Healthcare
Gilead Continues to Recover from Express Scripts Loss
Gilead Sciences was picked up by Anthem to provide its hepatitis C drug as the primary option for patients.
10:45am ET
Health and Healthcare
Is Gilead Already Coming Back Into Favor?
Is it possible that Gilead Sciences is already coming back into favor after just a week of being in the doghouse?
12:15pm ET
Health and Healthcare
Analysts Predict Big Value Trap for Gilead Investors
Analysts are beginning to make their calls for what the future will hold for Gilead Sciences, AbbVie and Express Scripts.
1:20pm ET
Health and Healthcare
What the AbbVie and Express Script Deal Means for Gilead
AbbVie and Express Scripts have entered into an exclusive agreement under which Express Scripts will distribute AbbVie's hepatitis treatment.
4:58pm ET
Investing
Significant Changes in Buffett and Berkshire Hathaway Holdings
courtesy of WhiteHouse.govBerkshire Hathaway Inc. (NYSE: BRK-A) has released its public equity holdings as of September 30, 2014. Warren Buffett’s portfolio has recently undergone some radical changes on the surface, some of…
11:45am ET
Health and Healthcare
Diplomat Turns Bunt Pricing Into Homerun for IPO Buyers
Diplomat Pharmacy priced its IPO shares at $13 on Thursday, but when the stock began trading Friday morning it opened at $16.
8:10am ET
Investing
Top Analyst Upgrades and Downgrades: JDSU, JD.com, Palo Alto, Petrobras, SeaWorld, Twitter, Yandex and More
These are the top analyst upgrades, downgrades and initiations covered by 24/7 Wall St. on Thursday, September 11, 2014.
9:50am ET
Investing
Walgreen Crumbles on Decision to Avoid Tax Inversion
Walgreen has decided to maintain its U.S. home, disappointing some big investors but very likely dodging a nasty reaction from U.S. consumers and the federal government.
Paul Ausick